{"data":[{"accessionNo":"0001950047-26-009530","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Daniel Barber","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":50000,"aggregateMarketValue":244000,"unitsOutstanding":125511648,"approxSaleDate":"2026-09-15","exchange":"NASDAQ","filedAt":"2026-09-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-009243","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Sherry M. Korczynski","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8750,"aggregateMarketValue":45587.5,"unitsOutstanding":125511648,"approxSaleDate":"2026-09-09","exchange":"NASDAQ","filedAt":"2026-09-09","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-008250","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Daniel Barber","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":106250,"unitsOutstanding":125511648,"approxSaleDate":"2026-08-17","exchange":"NASDAQ","filedAt":"2026-08-17","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-007131","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Daniel Barber","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":101000,"unitsOutstanding":125450119,"approxSaleDate":"2026-07-15","exchange":"NASDAQ","filedAt":"2026-07-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-006421","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"JULIE KROP","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":118000,"unitsOutstanding":125450119,"approxSaleDate":"2026-06-23","exchange":"NASDAQ","filedAt":"2026-06-23","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-006103","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Daniel Barber","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":104250,"unitsOutstanding":125450119,"approxSaleDate":"2026-06-15","exchange":"NASDAQ","filedAt":"2026-06-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-26-004630","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Daniel Barber","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8257,"aggregateMarketValue":39055.61,"unitsOutstanding":125450119,"approxSaleDate":"2026-05-15","exchange":"NASDAQ","filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001968582-25-001073","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Carl N. Kraus","relationship":"Affiliate","securityClass":"Common Stock","broker":"J.P. Morgan Securities LLC","unitsToSell":53100,"aggregateMarketValue":286209,"unitsOutstanding":99723635,"approxSaleDate":"2025-11-17","exchange":"NASDAQ","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001968582-25-000998","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Carl N. Kraus","relationship":"Officer","securityClass":"Common Stock","broker":"J.P. Morgan Securities LLC","unitsToSell":40544,"aggregateMarketValue":278943,"unitsOutstanding":99723635,"approxSaleDate":"2025-10-15","exchange":"NASDAQ","filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-25-007999","issuerCik":"0001398733","issuerName":"AQUESTIVE THERAPEUTICS INC","ticker":"AQST","personName":"CASSIE JUNG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":67575,"aggregateMarketValue":464916,"unitsOutstanding":99723635,"approxSaleDate":"2025-10-15","exchange":"NASDAQ","filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001628280-25-045063","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Peter Boyd","relationship":"Officer","securityClass":"Aquestive Therapeutics","broker":"Merrill","unitsToSell":10000,"aggregateMarketValue":70000,"unitsOutstanding":99723635,"approxSaleDate":"2025-10-15","exchange":"NASDAQ","filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001628280-25-043082","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"Peter Boyd","relationship":"Officer","securityClass":"Aquestive Therapeutics","broker":"Merrill","unitsToSell":10000,"aggregateMarketValue":63000,"unitsOutstanding":99723635,"approxSaleDate":"2025-09-26","exchange":"NASDAQ","filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-25-007535","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"DANIEL BARBER","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":91343,"aggregateMarketValue":480464.18,"unitsOutstanding":99723635,"approxSaleDate":"2025-09-26","exchange":"NASDAQ","filedAt":"2025-09-26","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001950047-25-007378","issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","personName":"DANIEL R BARBER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":400,"aggregateMarketValue":1976,"unitsOutstanding":99723635,"approxSaleDate":"2025-09-19","exchange":"NASDAQ","filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"}],"updatedAt":"2026-10-25T02:17:15.762Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/aqst","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}